Search Results - A. K. Gopal

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MAR... by L. H. Sehn, K. Hübel, S. Luminari, A. Salar, B. E. Wahlin, A. K. Gopal, C. Bonnet, S. Paneesha, M. Trneny, H. Mashegu, C. Lihou, D. Li, C. W. Scholz

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL-DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF... by P. L. Zinzani, S. M. Ansell, F. Bosch, J. W. Friedberg, J. P. Marolleau, L. Arcaini, R. Garcia-Sanz, A. K. Gopal, C. Grande, R. Merryman, A. Pinto, S. D. Smith, J. C. Villasboas, D. Wallace, J. Fagerberg, J. G. Magalhaes, P. Armand

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P1276: DOSE RESPONSE PROFILE OF IGM-2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON-HODGKIN’S LYMPHOMA by M. K. Leabman, G. Hernandez, C. M. Ng, J. Tang, D. Pandya, K. C. Hart, K. Li, P. R. Hinton, J. So, I. Qazi, C. Y. Cheah, W. S. Kim, E. Budde, A. K. Gopal, T. Manley, C. H. Takimoto, A. M. Sinclair, S. F. Carroll, B. A. Keyt, M. F. Kotturi

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: